Dr. Amish Patel has over 18 years of leadership experience in global biopharma and biotech industry, providing strategic guidance throughout the entire biologic product life-cycle. Dr. Patel is responsible for critical oversight of Global Manufacturing, Quality Control, Quality Assurance and Supply Chain to produce Clinical and Commercial cancer therapies utilizing Calidi’s innovative oncolytic viral therapies with stem cell-based delivery platforms to treat a wide range of cancers with significant unmet needs.
Over the course of his career, he has led the development of over fifteen INDs, two commercial product approvals, and numerous PAS submissions. He was most recently, the Senior Director of Product Development at Emergent BioSolutions (formerly PaxVax, Inc., prior to acquisition), where he successfully built and directed cross-functional teams working on numerous biologic Clinical products.